Verition Fund Management »

Theravance Biopharma shares owned by Verition Fund Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $291k 34k 8.48
2022-12-31 $126k 11k 11.22

More positions owned by Verition Fund Management

Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
Amazon (AMZN)
Apple Put Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Netflix (NFLX)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
DTE Energy Company (DTE)
Sempra Energy (SRE)
Truist Financial Corp equities Put Option (TFC)
PPL Corporation Call Option (PPL)
Old National Ban (ONB)
Broadcom Put Option (AVGO)
NiSource (NI)

View all positions for Verition Fund Management

Top funds holding Theravance Biopharma

Weiss Asset Management LP[1
Newtyn Management
BlackRock
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
State Street Corporation
Geode Capital Management
D. E. Shaw & Co
Pictet Asset Management Holding SA
Jacobs Levy Equity Management
Bank of America Corporation
Morgan Stanley
Dimensional Fund Advisors

View all funds holding Theravance Biopharma